Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lmito Therapeutics Inc.

Clinical trials sponsored by Lmito Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new pill tame inflammatory bowel disease? Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Can a new pill tame inflammatory bowel disease?

Disease control Not yet recruiting

This phase 1 trial tests the safety and tolerability of LMT503, an oral drug intended for inflammatory bowel disease, in healthy adults aged 18 to 65. Participants receive either LMT503 or a placebo in single or multiple ascending doses, with some also checking how food affects t…

Phase 1 • Sponsor: Lmito Therapeutics Inc. • Aim: Disease control

Last updated Sep 03, 2026 00:00 UTC